HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combination therapy for segmental craniocervical dystonia (Meige syndrome) with aripiprazole, trihexyphenidyl, and botulinum toxin: three cases reports.

Abstract
Segmental craniocervical dystonia is characterized by blephalospasm and oromandibular dystonia and is also called Meige syndrome. The current treatment strategy including botulinum toxin (BTX) injections has not yet attained an acceptable level. We describe a long-term favorable response of a novel combination therapy with aripiprazole (ARP), trihexyphenidyl (THP), and BTX in three patients with segmental craniocervical dystonia. The symptoms of three patients responded promptly to the combination therapy with ARP 3-6 mg daily, THP 2-8 mg daily, and BTX. Although the patients were required to receive a BTX 50-100 IU injection every 3-6 months, their symptoms were kept in a satisfactory condition for up to 2 years without any adverse effects. ARP possesses the potential for dramatically improving dystonia. THP has the possibility to enhance the efficacy of ARP and prolong the effective period of BTX. It may be an important requisite to give all three agents together for a successful treatment. The combination therapy with ARP, THP, and BTX was well-tolerated and useful in controlling the symptoms of segmental craniocervical dystonia, however, the reason why this combination therapy succeeded is unknown. A further long-term follow-up is required to monitor the delayed neurological adverse effects.
AuthorsTsukasa Saito, Takayuki Katayama, Jun Sawada, Kohei Kano, Asuka Asanome, Kae Takahashi, Nobuyuki Sato, Naoyuki Hasebe
JournalNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (Neurol Sci) Vol. 36 Issue 2 Pg. 243-5 (Feb 2015) ISSN: 1590-3478 [Electronic] Italy
PMID25151364 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Dyskinesia Agents
  • Trihexyphenidyl
  • Aripiprazole
  • Botulinum Toxins
Topics
  • Adult
  • Anti-Dyskinesia Agents (administration & dosage)
  • Aripiprazole (administration & dosage)
  • Botulinum Toxins (administration & dosage)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Meige Syndrome (drug therapy)
  • Middle Aged
  • Treatment Outcome
  • Trihexyphenidyl (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: